Diseases, Conditions, Syndromes

Aspirin to fight an expensive global killer infection

Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood ...

Diseases, Conditions, Syndromes

Tuberculosis can be eradicated by 2045: experts

The world can eradicate tuberculosis by 2045 if the fight against the killer disease is properly funded, an international team of experts said Wednesday.

HIV & AIDS

One-month regimen noninferior for preventing HIV-related TB

(HealthDay)—For HIV-infected patients, a one-month regimen of rifapentine and isoniazid is noninferior to nine months of isoniazid alone for preventing tuberculosis, according to a study published in the March 14 issue ...

Medical research

Peptide derived from fungi kills TB bacteria

The discovery of the peptide as a possible future antibiotic was made by researchers who screened different antimicrobial peptides' ability to prevent the growth of Mycobacterium tuberculosis. The peptide they found comes ...

Diseases, Conditions, Syndromes

New tuberculosis drug may shorten treatment time for patients

A new experimental antibiotic for tuberculosis has been shown to be more effective against TB than isoniazid, a decades-old drug which is currently one of the standard treatments. In mouse studies, the new drug showed a much ...

Diseases, Conditions, Syndromes

Deadly drug-resistant TB a 'blinking red' global threat

Deadly, drug-resistant tuberculosis—as lethal as Ebola and tough to treat in even the best hospitals—is a "blinking red" worldwide threat, the head of a global health fund warned in an interview with AFP.

page 13 from 40